Related Experiment Video
Updated: May 14, 2026
Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters
Published on: August 22, 2014
Ras nanoclusters: a new drug target?
Kwang-Jin Cho1, John F Hancock
1Department of Integrative Biology and Pharmacology, The University of Texas Medical School, Houston, Houston, TX, USA.
Abstract:
Ras proteins on the plasma membrane are laterally segregated into transient nanoclusters that are essential for high-fidelity signal transmission by the Ras/MAPK cascade. The dynamics of Ras nanocluster assembly and disassembly control MAPK signal output. BRaf inhibitors paradoxically activate CRaf and MAPK signaling in Ras-transformed cells. In our recent study, we showed that BRaf inhibition significantly enhances nanoclustering of oncogenic K- and N-Ras, but not H-Ras by increasing the frequency of Ras nanocluster formation. This disrupted spatiotemporal dynamics of Ras nanocluster fully accounts for the observed effects of Raf inhibitors on Ras signal transmission. Here together with other studies, we propose that the dynamics of Ras nanoclusters may represent a novel target for future therapeutic intervention.
Insights
BRAF inhibitors boost Ras nanoclustering, altering MAPK signaling. This Ras nanocluster dynamics disruption explains paradoxical effects and suggests a new therapeutic target.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Cancer research
Background:
- Ras proteins form dynamic nanoclusters crucial for MAPK signaling.
- Ras/MAPK cascade fidelity depends on nanocluster assembly and disassembly.
- BRAF inhibitors paradoxically activate CRAF and MAPK signaling in Ras-transformed cells.
Purpose of the Study:
- Investigate how BRAF inhibition affects Ras nanoclustering.
- Determine the role of Ras nanocluster dynamics in BRAF inhibitor response.
- Identify novel therapeutic targets in Ras-driven cancers.
Main Methods:
- Utilized live-cell imaging techniques to observe Ras nanocluster formation.
- Quantified nanocluster assembly and disassembly dynamics.
- Analyzed the impact of BRAF inhibition on oncogenic K-Ras, N-Ras, and H-Ras nanoclustering.
Main Results:
- BRAF inhibition significantly increased K-Ras and N-Ras nanoclustering frequency.
- H-Ras nanoclustering was not affected by BRAF inhibition.
- Disrupted spatiotemporal dynamics of Ras nanoclusters fully explained observed signaling effects.
Conclusions:
- BRAF inhibition alters Ras nanocluster dynamics, specifically enhancing K-Ras and N-Ras clustering.
- The observed paradoxical activation of CRAF and MAPK signaling is attributable to these nanocluster dynamics.
- Ras nanocluster dynamics represent a potential novel therapeutic target for Ras-driven cancers.
